76 related articles for article (PubMed ID: 9096993)
1. Effect of long-acting somatostatin analog (Somatulin) on renal hyperfiltration in patients with IDDM.
Jacobs ML; Derkx FH; Stijnen T; Lamberts SW; Weber RF
Diabetes Care; 1997 Apr; 20(4):632-6. PubMed ID: 9096993
[TBL] [Abstract][Full Text] [Related]
2. Free and total insulin-like growth factor I (IGF-I), IGF-binding protein-1 (IGFBP-1), and IGFBP-3 and their relationships to the presence of diabetic retinopathy and glomerular hyperfiltration in insulin-dependent diabetes mellitus.
Janssen JA; Jacobs ML; Derkx FH; Weber RF; van der Lely AJ; Lamberts SW
J Clin Endocrinol Metab; 1997 Sep; 82(9):2809-15. PubMed ID: 9284701
[TBL] [Abstract][Full Text] [Related]
3. Differences between nisoldipine and lisinopril on glomerular filtration rates and albuminuria in hypertensive IDDM patients with diabetic nephropathy during the first year of treatment.
Rossing P; Tarnow L; Boelskifte S; Jensen BR; Nielsen FS; Parving HH
Diabetes; 1997 Mar; 46(3):481-7. PubMed ID: 9032106
[TBL] [Abstract][Full Text] [Related]
4. Effect of a somatostatin analogue, octreotide, on renal haemodynamics and albuminuria in acromegalic patients.
Dullaart RP; Meijer S; Marbach P; Sluiter WJ
Eur J Clin Invest; 1992 Jul; 22(7):494-502. PubMed ID: 1516598
[TBL] [Abstract][Full Text] [Related]
5. Short-term suppression of elevated growth hormone concentrations following insulin-like growth factor 1 administration in young adults with type 1 diabetes does not alter glomerular filtration or albumin excretion rates.
Williams RM; Yuen K; White D; Mallard B; Dalton RN; Acerini CL; Dunger DB
Clin Endocrinol (Oxf); 2006 Oct; 65(4):439-45. PubMed ID: 16984235
[TBL] [Abstract][Full Text] [Related]
6. Glomerular hyperfiltration in insulin-dependent diabetes mellitus is correlated with enhanced growth hormone secretion.
Blankestijn PJ; Derkx FH; Birkenhäger JC; Lamberts SW; Mulder P; Verschoor L; Schalekamp MA; Weber RF
J Clin Endocrinol Metab; 1993 Aug; 77(2):498-502. PubMed ID: 8345058
[TBL] [Abstract][Full Text] [Related]
7. Effect of long-acting somatostatin analog (SMS 201-995) on high glomerular filtration rate in insulin dependent diabetic patients.
Krempf M; Ranganathan S; Remy JP; Charbonnel B; Guillon J
Int J Clin Pharmacol Ther Toxicol; 1990 Jul; 28(7):309-11. PubMed ID: 2387655
[TBL] [Abstract][Full Text] [Related]
8. Increase in renal plasma flow and glomerular filtration rate during growth hormone treatment may be mediated by insulin-like growth factor I.
Hirschberg RR; Kopple JD
Am J Nephrol; 1988; 8(3):249-54. PubMed ID: 3239597
[TBL] [Abstract][Full Text] [Related]
9. Effects of the somatostatin analogue octreotide on renal function in conscious diabetic rats.
Bak M; Thomsen K; Flyvbjerg A
Nephrol Dial Transplant; 2001 Oct; 16(10):2002-7. PubMed ID: 11572888
[TBL] [Abstract][Full Text] [Related]
10. Effects of a long-acting formulation of octreotide on renal function and renal sodium handling in cirrhotic patients with portal hypertension: a randomized, double-blind, controlled trial.
Ottesen LH; Aagaard NK; Kiszka-Kanowitz M; Rehling M; Henriksen JH; Pedersen EB; Flyvbjerg A; Bendtsen F
Hepatology; 2001 Sep; 34(3):471-7. PubMed ID: 11526531
[TBL] [Abstract][Full Text] [Related]
11. Postprandial renal haemodynamic effect of lixisenatide vs once-daily insulin-glulisine in patients with type 2 diabetes on insulin-glargine: An 8-week, randomised, open-label trial.
Tonneijck L; Muskiet MHA; Smits MM; Hoekstra T; Kramer MHH; Danser AHJ; Diamant M; Joles JA; van Raalte DH
Diabetes Obes Metab; 2017 Dec; 19(12):1669-1680. PubMed ID: 28449402
[TBL] [Abstract][Full Text] [Related]
12. Glomerular filtration rate is increased in man by the infusion of both D,L-3-hydroxybutyric acid and sodium D,L-3-hydroxybutyrate.
Fioretto P; Trevisan R; Velussi M; Cernigoi A; De Riva C; Bressan M; Doria A; Pauletto N; Angeli P; De Donà C
J Clin Endocrinol Metab; 1987 Aug; 65(2):331-8. PubMed ID: 3298305
[TBL] [Abstract][Full Text] [Related]
13. Renal hemodynamic abnormalities in patients with short term insulin-dependent diabetes mellitus: role of renal prostaglandins.
Esmatjes E; Fernandez MR; Halperin I; Camps J; Gaya J; Arroyo V; Rivera F; Figuerola D
J Clin Endocrinol Metab; 1985 Jun; 60(6):1231-6. PubMed ID: 3858281
[TBL] [Abstract][Full Text] [Related]
14. Hyperfiltration in patients with type I diabetes mellitus: a prevalence study.
Cotroneo P; Manto A; Todaro L; Manto A; Pitocco D; Saponara C; Vellante C; Maussier ML; D'Errico G; Magnani P; Ghirlanda G
Clin Nephrol; 1998 Oct; 50(4):214-7. PubMed ID: 9799065
[TBL] [Abstract][Full Text] [Related]
15. A novel somatostatin analogue prevents early renal complications in the nonobese diabetic mouse.
Landau D; Segev Y; Afargan M; Silbergeld A; Katchko L; Podshyvalov A; Phillip M
Kidney Int; 2001 Aug; 60(2):505-12. PubMed ID: 11473633
[TBL] [Abstract][Full Text] [Related]
16. Unchanged renal haemodynamics following high dose ascorbic acid administration in normoalbuminuric IDDM patients.
Klein F; Juhl B; Christiansen JS
Scand J Clin Lab Invest; 1995 Feb; 55(1):53-9. PubMed ID: 7624737
[TBL] [Abstract][Full Text] [Related]
17. One-year follow-up of patients with acromegaly treated with fixed or titrated doses of lanreotide Autogel.
Caron P; Bex M; Cullen DR; Feldt-Rasmussen U; Pico Alfonso AM; Pynka S; Racz K; Schopohl J; Tabarin A; Valimaki MJ;
Clin Endocrinol (Oxf); 2004 Jun; 60(6):734-40. PubMed ID: 15163338
[TBL] [Abstract][Full Text] [Related]
18. Somatostatin analogue, octreotide, reduces increased glomerular filtration rate and kidney size in insulin-dependent diabetes.
Serri O; Beauregard H; Brazeau P; Abribat T; Lambert J; Harris A; Vachon L
JAMA; 1991 Feb; 265(7):888-92. PubMed ID: 1992187
[TBL] [Abstract][Full Text] [Related]
19. Chicken and fish diet reduces glomerular hyperfiltration in IDDM patients.
Pecis M; de Azevedo MJ; Gross JL
Diabetes Care; 1994 Jul; 17(7):665-72. PubMed ID: 7924775
[TBL] [Abstract][Full Text] [Related]
20. The effect of renal hyperfiltration on urinary inflammatory cytokines/chemokines in patients with uncomplicated type 1 diabetes mellitus.
Har R; Scholey JW; Daneman D; Mahmud FH; Dekker R; Lai V; Elia Y; Fritzler ML; Sochett EB; Reich HN; Cherney DZ
Diabetologia; 2013 May; 56(5):1166-73. PubMed ID: 23412605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
